Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.22.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenues:        
Revenues $ 2,288,676 $ 1,803,773 $ 6,725,144 $ 4,993,263
Costs and expenses:        
Costs of revenues 892,091 709,629 2,613,877 1,999,924
Research and development 285,189 238,957 808,373 687,059
Selling, general and administrative 216,489 183,040 623,229 537,580
Interest expense 39,978 39,092 116,142 117,358
Other expense (income), net 8,644 (7,348) 23,985 (269)
Income before income taxes 846,285 640,403 2,539,538 1,651,611
Provision for income taxes 115,625 73,233 22,876 207,316
Net income 730,660 567,170 2,516,662 1,444,295
Less: Net income (loss) attributable to non-controlling interest 88 (326) 229 (1,019)
Net income attributable to KLA $ 730,572 $ 567,496 $ 2,516,433 $ 1,445,314
Net income per share attributable to KLA        
Basic (in dollars per share) $ 4.87 $ 3.69 $ 16.64 $ 9.36
Diluted (in dollars per share) $ 4.83 $ 3.66 $ 16.52 $ 9.28
Weighted-average number of shares:        
Basic (in shares) 150,145 153,801 151,250 154,457
Diluted (in shares) 151,186 155,159 152,346 155,789
Product        
Revenues:        
Revenues $ 1,800,659 $ 1,375,320 $ 5,326,316 $ 3,758,838
Service        
Revenues:        
Revenues $ 488,017 $ 428,453 $ 1,398,828 $ 1,234,425